Indicators on BCAT-IN-4 You Should Know
The main stop level was the safety and tolerability of sifalimumab. Treatment-emergent adverse events (AEs) and critical AEs (SAEs) as well as their severity, final result, and any partnership to your review medication have been recorded from the investigator throughout the review. AEs were being regarded likely to be connected with review medicati